A type of diabetes drug might help ease joint pain in osteoarthritis by calming down pain signals in both the joint cells and nerves.
Evidence from Studies
Supporting (2)
Community contributions welcome
The study shows that GLP-1 drugs can help reduce knee pain in osteoarthritis, but it doesn't prove they work by affecting the specific joint and nerve signals the claim describes.
Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis
The study tested a diabetes drug called liraglutide, which is a type of GLP-1 drug, and found it reduced joint pain and inflammation in mice with osteoarthritis. This supports the idea that GLP-1 drugs can help with osteoarthritis pain.
Contradicting (1)
Community contributions welcome
Efficacy and Safety of GLP-1 Receptor Agonists for the Management of Knee Osteoarthritis: A Systematic Review and Meta-Analysis
The study looks at whether GLP-1 drugs help with knee osteoarthritis pain, but it doesn’t show how they might work, like the claim says they do by affecting joint and nerve cells.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.